Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
01.10.25
/
50%
€115.08
Target price
01.10.26
€133.73
Performance (%)
-8.29%
Price
16:44
€105.54
Summary
This prediction is currently active. With a performance of -8.29%, the BUY prediction for Abbott Laboratories by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 01.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.946% | -0.946% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $153.00 to $157.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-20.37%
16:44
16:44
